BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 9814673)

  • 1. Platelet activation markers and the primary antiphospholipid syndrome (PAPS).
    Joseph JE; Harrison P; Mackie IJ; Machin SJ
    Lupus; 1998; 7 Suppl 2():S48-51. PubMed ID: 9814673
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased circulating platelet-leucocyte complexes and platelet activation in patients with antiphospholipid syndrome, systemic lupus erythematosus and rheumatoid arthritis.
    Joseph JE; Harrison P; Mackie IJ; Isenberg DA; Machin SJ
    Br J Haematol; 2001 Nov; 115(2):451-9. PubMed ID: 11703349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extensive platelet activation in preeclampsia compared with normal pregnancy: enhanced expression of cell adhesion molecules.
    Konijnenberg A; Stokkers EW; van der Post JA; Schaap MC; Boer K; Bleker OP; Sturk A
    Am J Obstet Gynecol; 1997 Feb; 176(2):461-9. PubMed ID: 9065199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Flow cytometric detection of circulating activated platelets in primary antiphospholipid syndrome. Correlation with thrombocytopenia and anticardiolipin antibodies.
    Fanelli A; Bergamini C; Rapi S; Caldini A; Spinelli A; Buggiani A; Emmi L
    Lupus; 1997; 6(3):261-7. PubMed ID: 9104734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet activation and turnover in the primary antiphospholipid syndrome.
    Joseph JE; Donohoe S; Harrison P; Mackie IJ; Machin SJ
    Lupus; 1998; 7(5):333-40. PubMed ID: 9696137
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet microparticles and soluble P selectin in peripheral artery disease: relationship to extent of disease and platelet activation markers.
    Tan KT; Tayebjee MH; Lynd C; Blann AD; Lip GY
    Ann Med; 2005; 37(1):61-6. PubMed ID: 15902848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Can flow cytometric detection of platelet activation early in pregnancy predict the occurrence of preeclampsia? A prospective study.
    Konijnenberg A; van der Post JA; Mol BW; Schaap MC; Lazarov R; Bleker OP; Boer K; Sturk A
    Am J Obstet Gynecol; 1997 Aug; 177(2):434-42. PubMed ID: 9290465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preanalytical requirements for flow cytometric evaluation of platelet activation: choice of anticoagulant.
    Mody M; Lazarus AH; Semple JW; Freedman J
    Transfus Med; 1999 Jun; 9(2):147-54. PubMed ID: 10354385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High plasma serotonin levels in primary pulmonary hypertension. Effect of long-term epoprostenol (prostacyclin) therapy.
    Kéreveur A; Callebert J; Humbert M; Hervé P; Simonneau G; Launay JM; Drouet L
    Arterioscler Thromb Vasc Biol; 2000 Oct; 20(10):2233-9. PubMed ID: 11031209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet membrane early activation markers during prolonged storage.
    Matsubayashi H; Weidner J; Miraglia CC; McIntyre JA
    Thromb Res; 1999 Feb; 93(4):151-60. PubMed ID: 10064270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Index for platelet activation].
    Nomura S
    Nihon Naika Gakkai Zasshi; 2000 Jun; 89(6):1077-82. PubMed ID: 10892180
    [No Abstract]   [Full Text] [Related]  

  • 12. [Expression of platelet activation markers--selectin P and glycoprotein CD63 during hemodialysis].
    Walter-Croneck A; Belniak-Legieć E; Janicka L; Madro E; Krawczyk P
    Pol Arch Med Wewn; 1997 Nov; 98(11):424-30. PubMed ID: 9594560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paradoxical inhibition of fibrinogen binding and potentiation of alpha-granule release by specific types of inhibitors of glycoprotein IIb-IIIa.
    Schneider DJ; Taatjes DJ; Sobel BE
    Cardiovasc Res; 2000 Jan; 45(2):437-46. PubMed ID: 10728364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyporeactivity of neonatal platelets is not caused by preactivation during birth.
    Grosshaupt B; Muntean W; Sedlmayr P
    Eur J Pediatr; 1997 Dec; 156(12):944-8. PubMed ID: 9453378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cilostazol inhibits the expression of activation-dependent membrane surface glycoprotein on the surface of platelets stimulated in vitro.
    Inoue T; Sohma R; Morooka S
    Thromb Res; 1999 Feb; 93(3):137-43. PubMed ID: 10030830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Blood platelet activation markers in patients with acute cerebral infarction during the earliest stage of the disease--evaluation using flow cytometry methods].
    Belniak-Legieć E; Stelmasiak Z
    Neurol Neurochir Pol; 2000; 34(5):853-64. PubMed ID: 11253475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelet-surface glycoproteins in healthy and preeclamptic mothers and their newborn infants.
    Kühne T; Ryan G; Blanchette V; Semple JW; Hornstein A; Mody M; Chang W; McWhirter L; Freedman J
    Pediatr Res; 1996 Dec; 40(6):876-80. PubMed ID: 8947966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro comparison study of CD63 and CD62P expression after contacting leukocyte filters.
    Fukunaga K; Shimoyama T; Yamaji K; Yamane S; Sueoka A; Nosé Y
    Artif Organs; 1999 Jan; 23(1):108-13. PubMed ID: 9950188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Impact of shear stress on expression of platelet membrane glycoproteins].
    Li M; Cong Y; Deng X; Hu J; Qin X
    Zhonghua Yi Xue Za Zhi; 2002 Feb; 82(4):267-70. PubMed ID: 11953177
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Platelet activation in cardiology: methods, indications and therapeutic perspectives].
    Hézard N; Metz D; Simon G; Droullé C; Daliphard S; Potron G
    J Mal Vasc; 1999 Oct; 24(4):288-93. PubMed ID: 10582178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.